跳至主要内容
临床试验/NCT03823105
NCT03823105已完成不适用

Validation of Non-invasive Miniature Optical Sensors for Scoring Sleep Stages: a Prospective, Method-comparison, Proof of Concept, Single-centre Phase IV Study

Insel Gruppe AG, University Hospital Bern2 个研究点 分布在 1 个国家目标入组 69 人开始时间: 2018年12月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
69
试验地点
2
主要终点
The total time in non-REM sleep (stages 1-3), REM sleep, and awake after sleep onset

研究概览

简要总结

Validation of two devices with optical sensor in healthy participants and patients with sleep wake disorders.

详细描述

The objective of this study is to evaluate and optimize a method of detecting sleep and sleep stages based on a new algorithm combining actigraphy and heart rate variability (measured by optical analysis of the pulse wave) to determine sleep architecture (segmented into three phases: WAKE, REM and NREM) with high accuracy compared to the gold standard polysomnography.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 ≤ Age ≤ 80 years
  • Suspected sleep wake disorder (sleep apnea, sleep movement disorders, hypersomnia, parasomnia)
  • Written informed consent

排除标准

  • Skin condition with eczema or damaged skin
  • Ischemia (cutaneous)
  • Allergy against nickel
  • Allergy against silicone
  • Current treatment with vasoactive drugs (e.g. beta-blockers, calcium channel antagonists, nitroglycerin, etc.) and/or antidepressive drugs (e.g. serotonin reuptake inhibitors, etc.).
  • Known infection with multiresistant bacteria
  • Implanted devices (e.g. pacemaker, pumps)
  • Rhythmogenic heart disease (e.g. resting heart rate > 120/min)
  • Severe or untreated arterial hypertension (blood pressure > 140mmHg systolic, >90mmHg diastolic)
  • Hypotension (blood pressure < 90mmHg systolic, < 60 mmHg diastolic)
  • Current alcohol or drug abuse, alcohol consumption the same day as the study
  • Consumption of coffee 7h before
  • Dark skin pigmentation
  • Severe metabolic disease (e.g. diabetes)
  • Pregnancy or lactation
  • Physical handicap effecting the two arms
  • Wound in the wrist region
  • Too large or too small wrist
  • Healthy subjects
  • Inclusion criteria:
  • 18 ≤ Age ≤ 80 years
  • Written informed consent
  • Exclusion criteria:
  • Skin condition with eczema or damaged skin
  • Ischemia (cutaneous)
  • Allergy against nickel
  • Allergy against silicone
  • Any Medication (except birth control pill)
  • Known infection with multiresistant bacteria
  • Implanted devices (e.g. pacemaker, pumps)
  • Rhythmogenic heart disease (e.g. resting heart rate > 120/min)
  • Severe or untreated arterial hypertension (blood pressure > 140mmHg systolic, >90mmHg diastolic)
  • Hypotension (blood pressure < 90mmHg systolic, < 60 mmHg diastolic)
  • Current alcohol or drug abuse, alcohol consumption the same day as the study
  • Consumption of coffee 7h before
  • Implanted devices (e.g. pacemaker, pumps)
  • Known sleep-wake disorders
  • Dark skin pigmentation
  • Severe metabolic disease (e.g. diabetes)
  • Pregnancy or lactation
  • Physical handicap effecting the two arms
  • Wound in the wrist region
  • Too large or too small wrist

结局指标

主要结局

The total time in non-REM sleep (stages 1-3), REM sleep, and awake after sleep onset

时间窗: 1 night

Diagnostic accuracy of the new algorithm compared to the Gold Standard full polysomnography

Total Sleep Time (TST) and sleep architecture (distribution of sleep stages)

时间窗: 1 night

Diagnostic accuracy of the new algorithm compared to the Gold Standard full polysomnography

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Validation of Non-invasive Miniature Optical Sensors... | 临床试验